WWOX in brain development and disease: Molecular mechanisms and therapeutic opportunities
Gene therapy rescues seizures and survival in mice with rare WWOX epilepsy, establishing a clear path toward testing this approach in children with this devastating condition.
This comprehensive review synthesizes mechanisms of WWOX-related epileptic encephalopathy (WOREE syndrome), a rare severe neurodevelopmental disorder with early mortality, including preclinical evidence that AAV-based WWOX restoration rescues seizures, myelination deficits, and survival in mouse models. The translational pathway to AAV gene therapy is clearly outlined, making this a high-priority rare disease candidate for clinical development monitoring.
What the study was
- Study design
- Narrative review with preclinical model synthesis
- Population
- WOREE syndrome patients (WWOX-related epileptic encephalopathy); also preclinical mouse models
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Neurobiology of Disease
Why it surfaced
WOREE syndrome is ultra-rare with early mortality and high unmet need; AAV gene therapy rescue in preclinical models represents a plausible translational path. Review format limits design quality score, but unmet need dimension elevates priority.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.